Response to Paulo et al.: Japanese patients equally likely to benefit from aprepitant for chemotherapy‐induced nausea and vomiting prevention
Cancer Science (impact factor: 3.33). 04/2011; 102(5):1113 - 1113. DOI:10.1111/j.1349-7006.2011.01906.x pp.1113 - 1113
ABSTRACT (Cancer Sci 2011; 102: 1113)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.